No Detail Found!

Canakinumab treatment in four children with colchicine resistant familar mediterranean fever.

Author(s)
Solmaz Ozkan Cumra State Hospital,Cumra, Konya, Turkey
Bulent Atas Division of Pediatric Nephrology,Department of Pediatrics,Meram Medical Faculty,University of Necmettin,Erbakan,Meram,Konya,Turkey.
Abstract
Familial Mediterranean Fever (FMF) is an autosomal recessive and autoinflammatory disease, characterized with inflammation of serous membranes such as peritoneum, pleura, synovium with fever and pain. Colchicine is the main treatment of FMF, but 5-10 % of patients are unresponsive to colchicine. We report using anti-interleukin-1 agents anakinra and canakinumab in four colchicine-resistant patients who were successfully treated. Three of the patients were siblings.
Publication Details
Page(s) 945-947
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 67, Issue: 6, Year: 2017

Request the full text from PASTIC

0

Citations

0

Downloads

81

Views